Global Advanced Wound-Management Market Experiences Growth
|
By HospiMedica International staff writers Posted on 24 Nov 2009 |
|
A new report by GlobalData (London, United Kingdom) identifies and assesses the key trends shaping and driving the global advanced wound management market.
According to GlobalData, the global advanced wound management market was valued at U.S. $3.6 billion in 2008 and forecasts that it will grow by 4.7% annually for the next seven years, reaching $5 billion by 2015. This growth will primarily be driven by an increase in the incidence of chronic wounds such as venous, diabetic, and pressure ulcers, increased patient awareness, and technology advancement in the products themselves.
Foams and hydrofibers remain the key market segments that are driving growth within the advanced wound management market; together, these two segments accounted for 67% of the overall advanced wound management market in 2008. According to the report, the foams market is forecast to grow at a 5.4% compound annual growth rate (CAGR) till 2015, due to faster healing of certain types of wounds and reduced patient follow-up, which will limit the cost factor. The hydrofibers market is forecast to grow at 4.7% CAGR, and is expected to be driven by technological advancements and an increase in the number of diabetic patients.
Globally, the United States remains the largest advanced wound management market, and is expected to continue to be so. The U.S. market was valued at $1.5 billion in 2008 and is forecast to grow at a 4.9% CAGR, reaching a value of $2.2 billion by 2015. The U.S. market is expected to be driven by a growing chronic wound population and increased levels of patient awareness. Companies such as Smith & Nephew, Molnlycke Healthcare, Convatec, and Covidien remain the leading competitors in the global advanced wound management market; together, these companies accounted for 56% of the global market share in 2008, with Smith & Nephew (London, United Kingdom) the market leader with a share of 27%. However, with more than 35 products in different developmental stages in 2008, and many of these expected to hit the market in the next few years, a shift in the prevailing competitive landscape cannot be ruled out. If approved, these pipeline products could lead to an intensely competitive market landscape, and the existing market leaders need to be prepared to manage these future challenges.
Related Links:
GlobalData
Smith & Nephew
According to GlobalData, the global advanced wound management market was valued at U.S. $3.6 billion in 2008 and forecasts that it will grow by 4.7% annually for the next seven years, reaching $5 billion by 2015. This growth will primarily be driven by an increase in the incidence of chronic wounds such as venous, diabetic, and pressure ulcers, increased patient awareness, and technology advancement in the products themselves.
Foams and hydrofibers remain the key market segments that are driving growth within the advanced wound management market; together, these two segments accounted for 67% of the overall advanced wound management market in 2008. According to the report, the foams market is forecast to grow at a 5.4% compound annual growth rate (CAGR) till 2015, due to faster healing of certain types of wounds and reduced patient follow-up, which will limit the cost factor. The hydrofibers market is forecast to grow at 4.7% CAGR, and is expected to be driven by technological advancements and an increase in the number of diabetic patients.
Globally, the United States remains the largest advanced wound management market, and is expected to continue to be so. The U.S. market was valued at $1.5 billion in 2008 and is forecast to grow at a 4.9% CAGR, reaching a value of $2.2 billion by 2015. The U.S. market is expected to be driven by a growing chronic wound population and increased levels of patient awareness. Companies such as Smith & Nephew, Molnlycke Healthcare, Convatec, and Covidien remain the leading competitors in the global advanced wound management market; together, these companies accounted for 56% of the global market share in 2008, with Smith & Nephew (London, United Kingdom) the market leader with a share of 27%. However, with more than 35 products in different developmental stages in 2008, and many of these expected to hit the market in the next few years, a shift in the prevailing competitive landscape cannot be ruled out. If approved, these pipeline products could lead to an intensely competitive market landscape, and the existing market leaders need to be prepared to manage these future challenges.
Related Links:
GlobalData
Smith & Nephew
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Immobilization System
Cranial 4Pi Immobilization
Multi-Chamber Washer-Disinfector
WD 390
Latest Business News
- Endologix Adds FDA-Cleared Peripheral Thrombectomy System
- Artivion Adds FDA-Approved NEXUS System to Aortic Arch Portfolio
- Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read more
Surgical Techniques
view channel
CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
Thyroid and breast surgeries are often performed in confined anatomical spaces near critical structures, making precise dissection and controlled thermal management essential. As the global disease burden... Read more
3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
Tetralogy of Fallot is one of the most common congenital heart problems and often requires surgery in infancy. Many survivors later develop conduction abnormalities because the cardiac electrical system... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
Point of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read more
Business
view channel
Endologix Adds FDA-Cleared Peripheral Thrombectomy System
Endologix (Santa Rosa, CA, USA) has acquired the Pounce Thrombectomy System from Surmodics, with the transaction closing on May 18, 2026. The FDA-cleared system is indicated for the non-surgical removal... Read more
